Managing Toxicities from Chronic Myeloid Leukemia Treatment
2 意见
• 07/08/23
0
0
嵌入
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论